세계의 근접치료 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Brachytherapy Market size is anticipated to grow from USD 1.09 Billion in 2024 to USD 2.12 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.72% during the forecast period of 2026 to 2033.

The brachytherapy market is experiencing significant growth, driven by the increasing prevalence of cancer and the demand for targeted treatment options. Brachytherapy, a form of radiation therapy that involves placing radioactive sources directly within or near a tumor, offers several advantages over traditional external beam radiation therapy, including reduced exposure to surrounding healthy tissues and improved treatment precision. As healthcare providers seek to enhance patient outcomes and minimize side effects, the adoption of brachytherapy is expected to rise, positioning this market for robust expansion. The growing body of clinical evidence supporting the efficacy of brachytherapy in treating various cancers, including prostate, breast, and cervical cancers, is further fueling this trend.

Moreover, advancements in brachytherapy technologies are driving innovation within the market. The development of new radioactive isotopes, improved delivery systems, and advanced imaging techniques is enhancing the effectiveness and safety of brachytherapy procedures. These innovations not only improve treatment outcomes but also contribute to a more streamlined workflow for healthcare providers. As research continues to explore new applications for brachytherapy, such as in combination with immunotherapy and other treatment modalities, the market is likely to expand further, driven by the promise of improved patient care and outcomes.

Additionally, the growing emphasis on personalized medicine is shaping the brachytherapy landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable brachytherapy solutions is likely to rise. This trend is particularly relevant in the context of advanced cancer treatments, where understanding the specific characteristics of a tumor can significantly impact treatment decisions. As the brachytherapy market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Dosage Type

• High-Dose Rate (HDR) Brachytherapy
• Low-Dose Rate (LDR) Brachytherapy

By Product

• Seeds
• Applicators & Afterloaders
• Electronic Brachytherapy

By Application

• Prostate Cancer
• Gynaecological Cancer
• Breast Cancer
• Others
• COMPANIES PROFILED
• Varian Medical Systems Inc.
• Becton
• Dickinson & Company
• Elekta AB
• Isoray Medical Inc.
• Eckert & Ziegler BEBIG
• iCAD Inc.
• CIVCO Medical Solutions
• Theragenics Corporation
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BRACHYTHERAPY INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Dosage Type
  • 3.7.2 Market Attractiveness Analysis By Product
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY DOSAGE TYPE

• 5.1. Overview By Dosage Type
• 5.2. Historical and Forecast Data Analysis By Dosage Type
• 5.3. High-Dose Rate (HDR) Brachytherapy Historic and Forecast Sales By Regions
• 5.4. Low-Dose Rate (LDR) Brachytherapy Historic and Forecast Sales By Regions

6. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY PRODUCT

• 6.1. Overview By Product
• 6.2. Historical and Forecast Data Analysis By Product
• 6.3. Seeds Historic and Forecast Sales By Regions
• 6.4. Applicators & Afterloaders Historic and Forecast Sales By Regions
• 6.5. Electronic Brachytherapy Historic and Forecast Sales By Regions

7. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY APPLICATION

• 7.1. Overview By Application
• 7.2. Historical and Forecast Data Analysis By Application
• 7.3. Prostate Cancer Historic and Forecast Sales By Regions
• 7.4. Gynaecological Cancer Historic and Forecast Sales By Regions
• 7.5. Breast Cancer Historic and Forecast Sales By Regions
• 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL BRACHYTHERAPY MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BRACHYTHERAPY COMPANIES

• 9.1. Brachytherapy Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF BRACHYTHERAPY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Varian Medical Systems Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Becton
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Dickinson & Company
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Elekta AB
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Isoray Medical Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Eckert & Ziegler BEBIG
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. ICAD Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. CIVCO Medical Solutions
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Theragenics Corporation
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies